 Paul Rozance
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 65 | 2023 | 764 | 7.140 |
Why?
| | Hypoglycemia | 27 | 2022 | 387 | 6.990 |
Why?
| | Glucose | 41 | 2023 | 897 | 6.500 |
Why?
| | Fetal Growth Retardation | 50 | 2023 | 467 | 6.460 |
Why?
| | Fetus | 40 | 2023 | 700 | 6.120 |
Why?
| | Placental Insufficiency | 20 | 2023 | 102 | 4.970 |
Why?
| | Insulin | 41 | 2023 | 2079 | 4.840 |
Why?
| | Blood Glucose | 30 | 2021 | 1828 | 3.770 |
Why?
| | Islets of Langerhans | 12 | 2021 | 726 | 3.570 |
Why?
| | Amino Acids | 19 | 2023 | 448 | 3.200 |
Why?
| | Insulin-Secreting Cells | 13 | 2021 | 317 | 3.020 |
Why?
| | Pregnancy | 79 | 2023 | 5518 | 2.840 |
Why?
| | Fetal Development | 14 | 2023 | 246 | 2.270 |
Why?
| | Insulin-Like Growth Factor I | 7 | 2023 | 286 | 2.220 |
Why?
| | Hyperinsulinism | 7 | 2020 | 103 | 2.190 |
Why?
| | Leucine | 8 | 2022 | 102 | 2.110 |
Why?
| | Liver | 18 | 2021 | 1637 | 2.100 |
Why?
| | Hyperglycemia | 7 | 2021 | 292 | 2.080 |
Why?
| | Pancreas | 12 | 2021 | 276 | 2.030 |
Why?
| | Infant, Newborn, Diseases | 5 | 2019 | 104 | 1.820 |
Why?
| | Infant, Premature | 7 | 2021 | 476 | 1.750 |
Why?
| | Placenta | 12 | 2023 | 626 | 1.650 |
Why?
| | Muscle, Skeletal | 15 | 2022 | 1472 | 1.480 |
Why?
| | Animals | 77 | 2023 | 31706 | 1.370 |
Why?
| | Myoblasts | 3 | 2021 | 76 | 1.360 |
Why?
| | Infant, Newborn | 24 | 2022 | 5045 | 1.330 |
Why?
| | Hypoxia | 6 | 2021 | 958 | 1.310 |
Why?
| | Fetal Blood | 9 | 2021 | 270 | 1.280 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 249 | 1.230 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 47 | 1.230 |
Why?
| | Gestational Age | 14 | 2021 | 760 | 1.220 |
Why?
| | Female | 89 | 2023 | 59499 | 1.180 |
Why?
| | Glucagon | 8 | 2022 | 92 | 1.040 |
Why?
| | Hepatocyte Growth Factor | 2 | 2016 | 32 | 0.990 |
Why?
| | Diabetes, Gestational | 3 | 2022 | 281 | 0.830 |
Why?
| | Placental Lactogen | 5 | 2022 | 20 | 0.810 |
Why?
| | Maternal-Fetal Exchange | 6 | 2021 | 151 | 0.790 |
Why?
| | Hindlimb | 3 | 2021 | 130 | 0.780 |
Why?
| | Signal Transduction | 9 | 2021 | 4513 | 0.770 |
Why?
| | Gluconeogenesis | 6 | 2019 | 62 | 0.750 |
Why?
| | Streptozocin | 1 | 2021 | 16 | 0.750 |
Why?
| | Muscle Proteins | 3 | 2022 | 210 | 0.740 |
Why?
| | NF-kappa B | 2 | 2021 | 641 | 0.710 |
Why?
| | Cell Proliferation | 5 | 2021 | 2187 | 0.690 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 66 | 0.610 |
Why?
| | Anemia | 2 | 2017 | 143 | 0.610 |
Why?
| | Catecholamines | 2 | 2017 | 94 | 0.570 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2016 | 32 | 0.570 |
Why?
| | Surface-Active Agents | 1 | 2017 | 79 | 0.560 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 505 | 0.550 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 386 | 0.540 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 176 | 0.540 |
Why?
| | Respiratory System | 1 | 2017 | 137 | 0.530 |
Why?
| | Water Deprivation | 1 | 2016 | 8 | 0.530 |
Why?
| | RNA, Messenger | 7 | 2022 | 2553 | 0.530 |
Why?
| | Oxygen | 12 | 2023 | 854 | 0.530 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2016 | 47 | 0.520 |
Why?
| | Developmental Disabilities | 2 | 2015 | 237 | 0.510 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 718 | 0.510 |
Why?
| | Postpartum Period | 1 | 2018 | 278 | 0.510 |
Why?
| | Sweetening Agents | 1 | 2015 | 37 | 0.510 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2016 | 498 | 0.500 |
Why?
| | Infant, Small for Gestational Age | 2 | 2018 | 76 | 0.500 |
Why?
| | Caloric Restriction | 1 | 2016 | 90 | 0.480 |
Why?
| | Humans | 44 | 2023 | 114674 | 0.480 |
Why?
| | Pregnancy Complications | 3 | 2019 | 429 | 0.470 |
Why?
| | Disease Models, Animal | 14 | 2021 | 3535 | 0.470 |
Why?
| | Uterus | 5 | 2022 | 192 | 0.460 |
Why?
| | Acidosis | 2 | 2020 | 88 | 0.460 |
Why?
| | Endothelial Cells | 3 | 2018 | 687 | 0.450 |
Why?
| | Placental Circulation | 3 | 2021 | 56 | 0.450 |
Why?
| | Lactic Acid | 7 | 2023 | 275 | 0.440 |
Why?
| | Hypoglycemic Agents | 6 | 2022 | 1013 | 0.440 |
Why?
| | Stress, Physiological | 1 | 2016 | 378 | 0.420 |
Why?
| | Periodicals as Topic | 2 | 2017 | 181 | 0.420 |
Why?
| | Glucose Clamp Technique | 5 | 2020 | 181 | 0.400 |
Why?
| | Organ Size | 7 | 2021 | 434 | 0.400 |
Why?
| | Random Allocation | 7 | 2012 | 335 | 0.400 |
Why?
| | Malnutrition | 1 | 2012 | 62 | 0.390 |
Why?
| | Muscle Development | 3 | 2021 | 98 | 0.390 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2096 | 0.370 |
Why?
| | Dietary Supplements | 3 | 2012 | 460 | 0.360 |
Why?
| | Hepatocytes | 4 | 2023 | 195 | 0.360 |
Why?
| | Pulmonary Artery | 2 | 2018 | 1016 | 0.350 |
Why?
| | Male | 25 | 2023 | 55589 | 0.350 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 923 | 0.350 |
Why?
| | Insulins | 2 | 2022 | 32 | 0.340 |
Why?
| | Insulin Resistance | 7 | 2019 | 1072 | 0.340 |
Why?
| | Dietary Proteins | 1 | 2011 | 122 | 0.340 |
Why?
| | Infant | 9 | 2023 | 7961 | 0.330 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.320 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 373 | 0.310 |
Why?
| | Fetal Diseases | 3 | 2021 | 147 | 0.300 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 127 | 0.300 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2320 | 0.290 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 185 | 0.290 |
Why?
| | Infusion Pumps | 2 | 2021 | 31 | 0.270 |
Why?
| | Down-Regulation | 3 | 2017 | 594 | 0.270 |
Why?
| | Fetal Macrosomia | 2 | 2021 | 58 | 0.270 |
Why?
| | Up-Regulation | 4 | 2017 | 808 | 0.270 |
Why?
| | Amino Acids, Essential | 1 | 2006 | 12 | 0.260 |
Why?
| | History, 20th Century | 3 | 2017 | 264 | 0.260 |
Why?
| | Diazoxide | 2 | 2017 | 22 | 0.260 |
Why?
| | Glucose-6-Phosphatase | 4 | 2016 | 31 | 0.250 |
Why?
| | Breast Feeding | 2 | 2019 | 368 | 0.250 |
Why?
| | RNA Interference | 3 | 2021 | 433 | 0.240 |
Why?
| | Pediatrics | 5 | 2018 | 979 | 0.240 |
Why?
| | Sheep, Domestic | 6 | 2019 | 33 | 0.240 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 483 | 0.220 |
Why?
| | Chronic Disease | 4 | 2017 | 1578 | 0.220 |
Why?
| | Hydrocortisone | 5 | 2020 | 267 | 0.220 |
Why?
| | Arginine | 4 | 2012 | 238 | 0.220 |
Why?
| | Norepinephrine | 4 | 2020 | 201 | 0.210 |
Why?
| | Nervous System Diseases | 1 | 2006 | 255 | 0.210 |
Why?
| | Carbohydrates | 1 | 2022 | 55 | 0.210 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2020 | 23 | 0.200 |
Why?
| | Infusions, Intravenous | 4 | 2021 | 371 | 0.200 |
Why?
| | Diet, High-Fat | 2 | 2023 | 225 | 0.200 |
Why?
| | Fetal Weight | 3 | 2022 | 52 | 0.200 |
Why?
| | Glycogen | 3 | 2020 | 51 | 0.200 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 11 | 0.190 |
Why?
| | Carotid Arteries | 2 | 2013 | 180 | 0.190 |
Why?
| | Insulinoma | 1 | 2021 | 29 | 0.190 |
Why?
| | Chemokine CXCL10 | 1 | 2021 | 34 | 0.180 |
Why?
| | I-kappa B Kinase | 1 | 2021 | 50 | 0.180 |
Why?
| | Biosensing Techniques | 2 | 2014 | 100 | 0.180 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 157 | 0.180 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 64 | 0.180 |
Why?
| | Endotoxemia | 1 | 2021 | 86 | 0.180 |
Why?
| | Gene Silencing | 1 | 2021 | 171 | 0.180 |
Why?
| | Lipid Metabolism | 2 | 2020 | 444 | 0.180 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 67 | 0.170 |
Why?
| | Energy Intake | 1 | 2022 | 427 | 0.170 |
Why?
| | Chorioamnionitis | 1 | 2020 | 36 | 0.170 |
Why?
| | Metformin | 1 | 2023 | 276 | 0.170 |
Why?
| | Transcription Factors | 1 | 2007 | 1528 | 0.170 |
Why?
| | Drug Synergism | 1 | 2020 | 316 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2021 | 160 | 0.170 |
Why?
| | Extracellular Matrix | 2 | 2013 | 436 | 0.170 |
Why?
| | Receptor, Insulin | 2 | 2011 | 93 | 0.170 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2019 | 141 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 923 | 0.160 |
Why?
| | Phosphorylation | 3 | 2019 | 1569 | 0.150 |
Why?
| | Vascular Stiffness | 2 | 2013 | 407 | 0.150 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2018 | 25 | 0.150 |
Why?
| | Adipose Tissue | 1 | 2021 | 540 | 0.150 |
Why?
| | Neonatology | 1 | 2018 | 17 | 0.150 |
Why?
| | Cell Survival | 1 | 2021 | 1021 | 0.150 |
Why?
| | Transcription Factor RelA | 1 | 2018 | 82 | 0.150 |
Why?
| | Oxygen Consumption | 1 | 2020 | 588 | 0.150 |
Why?
| | Umbilical Cord | 2 | 2016 | 80 | 0.150 |
Why?
| | Cell Count | 1 | 2018 | 303 | 0.150 |
Why?
| | Infant, Extremely Premature | 1 | 2018 | 57 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2021 | 731 | 0.140 |
Why?
| | Enteral Nutrition | 1 | 2019 | 160 | 0.140 |
Why?
| | Overnutrition | 1 | 2017 | 30 | 0.140 |
Why?
| | Time Factors | 4 | 2012 | 6115 | 0.140 |
Why?
| | Infant Formula | 1 | 2017 | 74 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 398 | 0.140 |
Why?
| | Hemodynamics | 1 | 2021 | 1012 | 0.140 |
Why?
| | Arteries | 1 | 2018 | 247 | 0.140 |
Why?
| | Calcium | 1 | 2022 | 1108 | 0.130 |
Why?
| | Ultrasonography, Prenatal | 1 | 2018 | 236 | 0.130 |
Why?
| | Potassium Chloride | 2 | 2014 | 32 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1140 | 0.130 |
Why?
| | Blotting, Western | 4 | 2019 | 1147 | 0.130 |
Why?
| | Lower Extremity | 1 | 2019 | 335 | 0.130 |
Why?
| | Biomedical Research | 1 | 2022 | 585 | 0.130 |
Why?
| | Treatment Failure | 1 | 2017 | 331 | 0.130 |
Why?
| | Linear Models | 1 | 2018 | 768 | 0.130 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 31 | 0.120 |
Why?
| | Parenteral Nutrition | 1 | 2016 | 96 | 0.120 |
Why?
| | Cell Division | 1 | 2017 | 758 | 0.120 |
Why?
| | Mice, Knockout | 1 | 2021 | 2570 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 30 | 0.120 |
Why?
| | Nurseries, Hospital | 1 | 2014 | 4 | 0.120 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2710 | 0.120 |
Why?
| | Homeostasis | 1 | 2018 | 573 | 0.120 |
Why?
| | Endocrinology | 1 | 2015 | 70 | 0.110 |
Why?
| | Hydrochlorothiazide | 1 | 2014 | 8 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1016 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 39 | 0.110 |
Why?
| | Diuretics | 1 | 2014 | 66 | 0.110 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2018 | 329 | 0.110 |
Why?
| | Macrophages | 1 | 2020 | 1262 | 0.110 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.110 |
Why?
| | Premature Birth | 1 | 2016 | 276 | 0.100 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 52 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2016 | 497 | 0.100 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.100 |
Why?
| | Cell Size | 1 | 2012 | 80 | 0.100 |
Why?
| | Glucagon-Secreting Cells | 1 | 2012 | 20 | 0.100 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2012 | 16 | 0.100 |
Why?
| | Umbilical Arteries | 1 | 2012 | 41 | 0.100 |
Why?
| | Solutions | 1 | 2012 | 146 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 801 | 0.100 |
Why?
| | Hyperplasia | 1 | 2012 | 163 | 0.100 |
Why?
| | Heart | 1 | 2016 | 612 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 172 | 0.100 |
Why?
| | Vasodilator Agents | 1 | 2014 | 302 | 0.100 |
Why?
| | Hernia, Diaphragmatic | 1 | 2012 | 67 | 0.100 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 40 | 0.100 |
Why?
| | Mice | 4 | 2021 | 14869 | 0.100 |
Why?
| | Cell Aggregation | 1 | 2011 | 24 | 0.100 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 178 | 0.100 |
Why?
| | Mitosis | 1 | 2012 | 164 | 0.100 |
Why?
| | Infant Nutrition Disorders | 1 | 2011 | 11 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 86 | 0.090 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 256 | 0.090 |
Why?
| | Parenteral Nutrition, Total | 1 | 2011 | 27 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 244 | 0.090 |
Why?
| | Carbon Dioxide | 2 | 2012 | 218 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2011 | 149 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2019 | 452 | 0.090 |
Why?
| | Algorithms | 3 | 2018 | 1468 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 184 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 41 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2011 | 221 | 0.090 |
Why?
| | Intensive Care, Neonatal | 1 | 2010 | 39 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2479 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 180 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2251 | 0.080 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2011 | 133 | 0.080 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 36 | 0.080 |
Why?
| | Gene Expression | 2 | 2011 | 1421 | 0.080 |
Why?
| | Glycine | 2 | 2023 | 152 | 0.080 |
Why?
| | Apoptosis | 2 | 2019 | 2363 | 0.080 |
Why?
| | Guidelines as Topic | 1 | 2010 | 243 | 0.080 |
Why?
| | Cohort Studies | 1 | 2018 | 4895 | 0.080 |
Why?
| | Liver Glycogen | 1 | 2007 | 17 | 0.070 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 26 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4408 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 511 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 2 | 2020 | 9 | 0.070 |
Why?
| | Cell Movement | 1 | 2011 | 869 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1629 | 0.070 |
Why?
| | Lysine | 1 | 2009 | 242 | 0.070 |
Why?
| | Biological Transport | 2 | 2020 | 373 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2007 | 522 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2011 | 823 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2007 | 410 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 908 | 0.070 |
Why?
| | Adult | 3 | 2023 | 30546 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 823 | 0.060 |
Why?
| | Risk Factors | 2 | 2016 | 8632 | 0.060 |
Why?
| | Societies, Medical | 2 | 2020 | 663 | 0.060 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 213 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 3886 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| | Elastin | 2 | 2013 | 78 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 79 | 0.050 |
Why?
| | Glucose Transporter Type 3 | 1 | 2022 | 11 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2022 | 5 | 0.050 |
Why?
| | Birth Weight | 2 | 2018 | 440 | 0.050 |
Why?
| | Serine | 1 | 2023 | 126 | 0.050 |
Why?
| | Ruminants | 1 | 2022 | 6 | 0.050 |
Why?
| | Glucose Transporter Type 1 | 1 | 2022 | 42 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 55 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2017 | 9088 | 0.050 |
Why?
| | Blastocyst | 1 | 2021 | 44 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 159 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 37 | 0.050 |
Why?
| | Collagen | 2 | 2013 | 415 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2021 | 105 | 0.050 |
Why?
| | Placentation | 1 | 2021 | 40 | 0.050 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 38 | 0.050 |
Why?
| | Weight Gain | 1 | 2023 | 453 | 0.040 |
Why?
| | Astrocytoma | 1 | 2001 | 108 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 227 | 0.040 |
Why?
| | Research Personnel | 1 | 2022 | 149 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 156 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 1842 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 72 | 0.040 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 38 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 104 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 778 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 535 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 341 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 153 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 183 | 0.040 |
Why?
| | Lung | 1 | 2011 | 3561 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 387 | 0.040 |
Why?
| | Body Weight | 2 | 2012 | 869 | 0.040 |
Why?
| | Delphi Technique | 1 | 2018 | 160 | 0.040 |
Why?
| | Temperature | 1 | 2019 | 565 | 0.040 |
Why?
| | Fatal Outcome | 2 | 2012 | 284 | 0.030 |
Why?
| | Term Birth | 1 | 2016 | 19 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2008 | 424 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 537 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 79 | 0.030 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2016 | 101 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 36 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 720 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 344 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 293 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2014 | 211 | 0.030 |
Why?
| | Compliance | 1 | 2012 | 46 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2012 | 133 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1518 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 21 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 24 | 0.030 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 29 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 144 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 72 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 397 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 111 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 142 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 286 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 170 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 132 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 591 | 0.020 |
Why?
| | Stimulation, Chemical | 1 | 2011 | 56 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 396 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 313 | 0.020 |
Why?
| | Diseases in Twins | 1 | 2012 | 174 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2012 | 160 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 913 | 0.020 |
Why?
| | Trans-Activators | 1 | 2012 | 367 | 0.020 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2012 | 186 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Child | 2 | 2020 | 18412 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3408 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1394 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 52 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1551 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 463 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 290 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 233 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 146 | 0.020 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2007 | 7 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1538 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 307 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2011 | 640 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 358 | 0.020 |
Why?
| | United States | 1 | 2022 | 12182 | 0.020 |
Why?
| | Body Temperature | 1 | 2005 | 208 | 0.020 |
Why?
| | Hypertension | 1 | 2012 | 1056 | 0.010 |
Why?
| | Rats | 1 | 2010 | 4958 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1620 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9114 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 24 | 0.010 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 68 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 2508 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3046 | 0.010 |
Why?
|
|
Rozance's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|